InVivo Therapeutics Holdings Corporation / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€360.36K - Gross profit
-€360.36K - SG&A expenses
€4.96M - R&D expenses
€3.50M - EBITDA
-€8.05M - D&A
€360.36K - EBIT
-€8.34M - Interest expenses
€0.00 - EBT
-€8.00M - Tax expenses
-€356.07K - Net income
-€8.00M
Cash flow statement
- Net deferred tax
€511.37K - Non-cash items
-€509.65K - Changes in working capital
-€1.21M - Operating cash flow
-€8.69M - Capex
€38.61K - Other investing cash flow
€0.00 - Net investing cash flow
€42.90K - Total cash dividends paid
€0.00 - Issuance of common stock
€6.83M - Debt repayment
€0.00 - Other financing cash flow
€6.83M - Net financing cash flow
€6.83M - Foreign exchange effects
€0.00 - Net change in cash
-€1.82M - Cash at end of period
€7.41M - Free cash flow
-€8.65M
Balance sheet
- Cash and cash equivalents
€7.36M - Cash and short-term investments
€7.36M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€275.42K - Total current assets
€8.17M - Property, plant & equipment
€7.72K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€42.90K - Other non-current assets
€0.00 - Total non-current assets
€50.62K - Total assets
€8.22M - Accounts payable
€105.53K - Short-term debt
€0.00 - Other current liabilities
€465.89K - Total current liabilities
€571.43K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€571.43K - Common stock
€2.57K - Retained earnings
-€219.29M - Other equity
€226.94M - Total equity
€7.65M - Total liabilities and shareholders' equity
€8.22M
Company information
- Market capitalization
€849.47K - Employees
6 - Enterprise Value
-€14.41M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-104.6% Much better than peer group: -454.2% - ROA
-
-97.3% Much better than peer group: -135.2% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-1,027.5% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.33M